OXCT1 and neoplasm: A study has shown that targeting 3-oxoacid CoA-transferase 1 (OXCT1) to regulate ketone body metabolism in macrophages helps to reduce the depletion of CD8+ T cells, which in turn maintains their anti-tumor function and enhances immune responses [17].